Roivant Sciences Ltd (ROIV)
Payables turnover
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 911 | 27,964 | 13,128 | 8,966 | 2,057 |
Payables | US$ in thousands | 23,691 | 53,225 | 37,830 | 34,583 | 20,550 |
Payables turnover | 0.04 | 0.53 | 0.35 | 0.26 | 0.10 |
March 31, 2025 calculation
Payables turnover = Cost of revenue ÷ Payables
= $911K ÷ $23,691K
= 0.04
Based on the data provided, Roivant Sciences Ltd's payables turnover has shown an increasing trend over the years. It was 0.10 as of March 31, 2021, and has steadily increased to 0.26 as of March 31, 2022, further increasing to 0.35 as of March 31, 2023, and reaching 0.53 as of March 31, 2024.
However, there is a sudden drop to 0.00 as of March 31, 2025, which indicates a significant change in the company's payables turnover efficiency.
Overall, the increasing trend in payables turnover suggests that Roivant Sciences Ltd has been effectively managing its accounts payable, turning over its payables more frequently in the earlier years. The sudden decrease to 0.00 in 2025 could indicate a change in the company's payment practices or possibly a shift in its relationship with suppliers. Further analysis would be required to understand the reasons behind this abrupt change and its potential implications on the company's financial operations.
Peer comparison
Mar 31, 2025